Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Sees Large Growth in Short Interest

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) was the target of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 121,500 shares, a growth of 40.0% from the November 15th total of 86,800 shares. Based on an average daily volume of 81,500 shares, the short-interest ratio is currently 1.5 days.

Wall Street Analyst Weigh In

Several analysts recently issued reports on EKSO shares. HC Wainwright decreased their target price on Ekso Bionics from $10.00 to $9.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th. Lake Street Capital cut their price target on Ekso Bionics from $2.50 to $2.00 and set a “buy” rating on the stock in a report on Tuesday, October 29th. Finally, StockNews.com began coverage on Ekso Bionics in a research report on Friday. They set a “hold” rating on the stock.

Ekso Bionics Price Performance

EKSO stock traded up $0.00 on Friday, reaching $0.57. The company had a trading volume of 147,815 shares, compared to its average volume of 115,288. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.81 and a quick ratio of 2.14. The company’s fifty day moving average is $0.85 and its 200 day moving average is $1.03. Ekso Bionics has a 1 year low of $0.50 and a 1 year high of $3.13.

Ekso Bionics (NASDAQ:EKSO) last released its earnings results on Monday, October 28th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by ($0.02). Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. The business had revenue of $4.13 million for the quarter, compared to analysts’ expectations of $6.00 million. During the same quarter last year, the company posted ($0.24) earnings per share. As a group, equities analysts forecast that Ekso Bionics will post -0.48 EPS for the current fiscal year.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.